MaveQuest: a web resource for planning experimental tests of human variant effects

Abstract Summary Fully realizing the promise of personalized medicine will require rapid and accurate classification of pathogenic human variation. Multiplexed assays of variant effect (MAVEs) can experimentally test nearly all possible variants in selected gene targets. Planning a MAVE study involves identifying target genes with clinical impact, and identifying scalable functional assays for that target. Here, we describe MaveQuest, a web-based resource enabling systematic variant effect mapping studies by identifying potential functional assays, disease phenotypes and clinical relevance for nearly all human protein-coding genes. Availability and implementation MaveQuest service: https://mavequest.varianteffect.org/. MaveQuest source code: https://github.com/kvnkuang/mavequest-front-end/. Supplementary information Supplementary data are available at Bioinformatics online.

[1]  Paul Denny,et al.  Genenames.org: the HGNC and VGNC resources in 2019 , 2018, Nucleic Acids Res..

[2]  Xing-Ming Zhao,et al.  OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines , 2016, Nucleic Acids Res..

[3]  Alan F. Rubin,et al.  MaveDB: an open-source platform to distribute and interpret data from multiplexed assays of variant effect , 2019, Genome Biology.

[4]  C. Cole,et al.  The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers , 2018, Nature Reviews Cancer.

[5]  Frederick P. Roth,et al.  Multiplexed assays of variant effects contribute to a growing genotype–phenotype atlas , 2018, Human Genetics.

[6]  Michael J. Osborn,et al.  Rescuing yeast mutants with human genes. , 2007, Briefings in functional genomics & proteomics.

[7]  Ricardo Villamarín-Salomón,et al.  ClinVar: public archive of interpretations of clinically relevant variants , 2015, Nucleic Acids Res..

[8]  Jan Winter,et al.  GenomeCRISPR - a database for high-throughput CRISPR/Cas9 screens , 2016, Nucleic Acids Res..

[9]  Thomas Horn,et al.  GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update , 2012, Nucleic Acids Res..

[10]  Silvio C. E. Tosatto,et al.  InterPro in 2019: improving coverage, classification and access to protein sequence annotations , 2018, Nucleic Acids Res..

[11]  Maitreya J. Dunham,et al.  Variant Interpretation: Functional Assays to the Rescue. , 2017, American journal of human genetics.

[12]  Julie O. Culver,et al.  Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings. , 2015, Genetic testing and molecular biomarkers.

[13]  Patrick Aloy,et al.  A reference map of the human binary protein interactome , 2020, Nature.

[14]  Michael R. Hayden,et al.  Hunting human disease genes: lessons from the past, challenges for the future , 2013, Human Genetics.

[15]  Wylie Burke,et al.  Genetic Tests: Clinical Validity and Clinical Utility , 2014, Current protocols in human genetics.

[16]  Judith A. Blake,et al.  Model organism data evolving in support of translational medicine , 2018, Lab Animal.

[17]  Chunlei Liu,et al.  ClinVar: improving access to variant interpretations and supporting evidence , 2017, Nucleic Acids Res..

[18]  R. Altman,et al.  Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.

[19]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[20]  A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase , 2020, Genome Medicine.

[21]  Erik L. L. Sonnhammer,et al.  InParanoid 8: orthology analysis between 273 proteomes, mostly eukaryotic , 2014, Nucleic Acids Res..

[22]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2004, Nucleic Acids Res..

[23]  Lily Hoffman-Andrews.  The known unknown: the challenges of genetic variants of uncertain significance in clinical practice , 2017, Journal of law and the biosciences.

[24]  Kara Dolinski,et al.  An extended set of yeast-based functional assays accurately identifies human disease mutations , 2016, Genome research.

[25]  Holtzman Na,et al.  Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. , 1999, Journal of child and family nursing.

[26]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[27]  Kara Dolinski,et al.  The Princeton Protein Orthology Database (P-POD): A Comparative Genomics Analysis Tool for Biologists , 2007, PloS one.